These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11309625)

  • 21. Human immunodeficiency virus (HIV) in developing countries.
    French N; Kaleebu P; Pisani E; Whitworth JA
    Ann Trop Med Parasitol; 2006; 100(5-6):433-54. PubMed ID: 16899147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Forecasting the future of HIV epidemics: the impact of antiretroviral therapies & imperfect vaccines.
    Blower S; Schwartz EJ; Mills J
    AIDS Rev; 2003; 5(2):113-25. PubMed ID: 12876900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV/AIDS. Treatment and prevention exchange vows at international conference.
    Cohen J
    Science; 2008 Aug; 321(5891):902-3. PubMed ID: 18703717
    [No Abstract]   [Full Text] [Related]  

  • 24. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope.
    Emini EA; Koff WC
    Science; 2004 Jun; 304(5679):1913-4. PubMed ID: 15218131
    [No Abstract]   [Full Text] [Related]  

  • 25. British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008.
    de Ruiter A; Mercey D; Anderson J; Chakraborty R; Clayden P; Foster G; Gilling-Smith C; Hawkins D; Low-Beer N; Lyall H; O'Shea S; Penn Z; Short J; Smith R; Sonecha S; Tookey P; Wood C; Taylor G
    HIV Med; 2008 Aug; 9(7):452-502. PubMed ID: 18840151
    [No Abstract]   [Full Text] [Related]  

  • 26. AIDS treatment enters its 25th year.
    Nelson R
    Lancet Infect Dis; 2006 Aug; 6(8):466-7. PubMed ID: 16888874
    [No Abstract]   [Full Text] [Related]  

  • 27. Impact of genetic diversity of HIV-1 on diagnosis, antiretroviral therapy & vaccine development.
    Lal RB; Chakrabarti S; Yang C
    Indian J Med Res; 2005 Apr; 121(4):287-314. PubMed ID: 15817945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV genetic diversity: any implications for drug resistance?
    Jülg B; Goebel FD
    Infection; 2005 Aug; 33(4):299-301. PubMed ID: 16091906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. European guidelines for the clinical management and treatment of HIV-infected adults in Europe.
    AIDS; 2003 Jun; 17 Suppl 2():S3-26. PubMed ID: 12870523
    [No Abstract]   [Full Text] [Related]  

  • 30. Prospects for an AIDS vaccine.
    Desrosiers RC
    Nat Med; 2004 Mar; 10(3):221-3. PubMed ID: 14991035
    [No Abstract]   [Full Text] [Related]  

  • 31. HIV/AIDS. Malawi: a suitable case for treatment.
    Cohen J
    Science; 2002 Aug; 297(5583):927-9. PubMed ID: 12169711
    [No Abstract]   [Full Text] [Related]  

  • 32. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The evolution of HIV and its consequences.
    Apetrei C; Marx PA; Smith SM
    Infect Dis Clin North Am; 2004 Jun; 18(2):369-94. PubMed ID: 15145385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obstacles and progress toward development of a preventive HIV vaccine.
    Heyward WL; MacQueen KM; Jaffe HW
    J Int Assoc Physicians AIDS Care; 1997 Aug; 3(8):28-34. PubMed ID: 11364630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does the HIV-1deltakURNe vaccine strain hold the key to curbing HIV infection? An interview with Ronald Desrosiers, PhD.
    Desrosiers R
    J Int Assoc Physicians AIDS Care; 1998 Mar; 4(3):45-6. PubMed ID: 11365180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive value of primate models for AIDS.
    Haigwood NL
    AIDS Rev; 2004; 6(4):187-98. PubMed ID: 15700617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 and HIV-Associated Nephropathy 25 Years Later.
    Wyatt CM; Klotman PE
    Clin J Am Soc Nephrol; 2007 Jul; 2 Suppl 1():S20-4. PubMed ID: 17699507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survey of the temporal changes in HIV-1 replicative fitness in the Amsterdam Cohort.
    Gali Y; Berkhout B; Vanham G; Bakker M; Back NK; Ariën KK
    Virology; 2007 Jul; 364(1):140-6. PubMed ID: 17395236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AIDS in the Third World: how to stop the HIV infection?
    De Clercq E
    Verh K Acad Geneeskd Belg; 2007; 69(2):65-80. PubMed ID: 17550059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.